Berlusconi scores point off Bolloré in mogul feud 3 Apr 2018 Shares in the former prime minister’s Mediaset TV group jumped after it agreed to collaborate with Sky’s Italian unit. An investor in Mediaset, Vincent Bolloré’s Vivendi will gain from the deal. But, as Berlusconi and Sky grow closer, Bolloré’s own ambitions risk being sidelined.
Siemens’ slimming strategy is half-hearted 3 Apr 2018 A part-sale of medical unit Healthineers has failed to shrink the German company’s conglomerate discount. After all, the 84 bln euro group still spans trains, energy and factories. Siemens’ exit from the lighting and mobile businesses offers CEO Joe Kaeser a useful template.
Melrose wins battle for GKN, UK M&A may be loser 29 Mar 2018 The takeover specialist's 8 billion pound bid for engineering group GKN has won the day. It now needs a turnaround plan that squares with pledges that were made to placate politicians. And potential bidders for other UK companies know they face a more interventionist government.
CME stretches to kill NEX bidding war 29 Mar 2018 The Chicago Mercantile Exchange owner is buying Michael Spencer’s broker for 3.9 billion pounds. Meshing U.S. Treasury futures trading with NEX’s currency and bonds business is a good idea. The hefty premium may deter rival bidders but requires the deal to be perfectly executed.
Tricky Renault-Nissan deal would be rewarding 29 Mar 2018 The French and Japanese groups chaired by Carlos Ghosn may merge to create a carmaker that trades as a single stock. The Gallic state, which owns 15 pct of Renault, would put up roadblocks. But after 19 years of cooperation, margins are low enough to make the union worth a try.
Drug companies take the anti-Amazon pill 27 Mar 2018 Novartis is selling its consumer health assets to GSK for $13 bln. It makes sense for the former to focus on traditional drugs given the threat from e-commerce. For the latter, the purchase is less risky than a Pfizer deal and may still allow investment in its core business.
Carlyle’s $12.6 bln Akzo deal has good chemistry 27 Mar 2018 The U.S. private equity group is buying a speciality chemical unit that the Dutch company put on the block after a failed PPG bid. Carlyle knows the industry and has slashed costs at Axalta. While there may be less scope for huge cuts this time, decent returns are still on offer.
Dana keeps GKN defence hopes alive 26 Mar 2018 The U.S. car parts maker raised its cash and shares offer for GKN’s auto unit by $140 million to thwart Melrose’s bid for the whole UK engineering group. The extra cash only compensates for recent falls in Dana’s share price. But given how tight the race is, any increase helps.
Deutsche fund IPO flaunts sickly bank 23 Mar 2018 The German bank’s IPO of asset management arm DWS has failed to create value. The rump bank and listed manager are worth at least 3 bln euros less than Deutsche was before the spinoff. The loss shows the limits of corporate rejigging, and upheaval still facing CEO John Cryan.
GKN owners should stick with the devil they know 23 Mar 2018 The UK engineer’s shareholders must choose whether to accept Melrose Industries’ $11 bln hostile cash-and-share bid. The buyer has a record for turnarounds, while GKN has missed targets. But Melrose’s plans are vague and riskier. GKN deserves the benefit of the doubt.
Naspers selldown prolongs Tencent dependence 22 Mar 2018 The South African group is offloading shares worth up to $11 bln in the Chinese giant. But it’s keeping the remaining 31 pct for at least three years, and will invest the proceeds. Shareholders have little reason to give it any more credit for its highly profitable Tencent bet.
Reckitt may yet benefit from Pfizer’s poor timing 22 Mar 2018 The Dettol maker’s shares jumped after it pulled a bid for the U.S. group’s consumer arm. The auction coincided with CEO Rakesh Kapoor’s struggle to digest a big deal, and rival GSK’s need to focus elsewhere. If Pfizer delays the sale, Reckitt could limber up for a second shot.
Time for Germany to make Deutsche/Commerz happen 21 Mar 2018 The country’s two biggest banks are projected to scrape mid single-digit returns on tangible equity by 2019. A merger that cut a tenth of joint costs could get that closer to double-figures. It could also stabilise Deutsche and give Berlin an excuse to sell its Commerzbank stake.
Elliott’s Italian master plan needs state player 16 Mar 2018 The activist fund wants to oust top investor Vivendi from Telecom Italia’s board and sell its network. A stand-alone telco backbone might attract a higher valuation and be able to shoulder more debt. However, success hinges on state-backed investor CDP’s readiness to chip in.
Altice investors require a stomach of steel 16 Mar 2018 Patrick Drahi’s telecom group has lost half its market value in less than five months. Spinning off the U.S. arm is sensible. But the slimmed-down parent’s 31 billion euros of net debt is almost 15 times its implied equity value. That is a recipe for wild share price swings.
Elliott picks unusual allies for Italian battle 15 Mar 2018 Paul Singer’s hedge fund wants to oust Telecom Italia’s chairman and other directors backed by top shareholder Vivendi. Nominating well-connected locals improves its chances of success. Still, it’s odd to see the free market champion joining forces with the Italian establishment.
City’s Brexit trickle need not turn into an exodus 13 Mar 2018 Banks such as Goldman Sachs and Standard Chartered are already moving London-based bankers to Frankfurt. Losing the “passport” to the EU’s single market means more will go. But large-scale flight can be avoided – as long as UK regulators stick closely to EU rules.
German energy carve-up generates good sparks 12 Mar 2018 RWE is splitting its ailing Innogy unit in a 22 bln euro deal with rival E.ON. The former will focus on generating power, while the latter specialises in distribution. A knotty asset swap obscures the value picture. But the plan enjoys stronger logic than previous reshuffles.
Shell investors could live with a BHP shale punt 9 Mar 2018 The Anglo-Dutch oil major may bid with Blackstone for the miner’s $10 bln U.S. shale assets, Sky says. The business would be less risky for Shell’s balance sheet than drilling for traditional oil. And private equity’s high return targets could reduce the danger of overpaying.
Renault-Nissan will struggle to lose third wheel 7 Mar 2018 The Japanese group may buy France’s 15 pct Renault stake, according a Reuters report the carmakers deny. It’d ease the French group’s heavily discounted share price and a full merger may allow the alliance to cut more costs. But it’s hard to see politicians yielding full control.